Ausgabe 2/2018
Inhalt (29 Artikel)
Exercise to improve functional outcomes in persons with osteoporosis: a systematic review and meta-analysis
A. Varahra, I. B. Rodrigues, J. C. MacDermid, D. Bryant, T. Birmingham
The effect of exercise on bone mineral density in adult cancer survivors: a systematic review and meta-analysis
J. Dalla Via, R. M. Daly, S. F. Fraser
Standards of reporting: the use of CONSORT PRO and CERT in individuals living with osteoporosis
D. E. Mack, P. M. Wilson, E. Santos, K. Brooks
Osteoporosis and bone mineral density in patients with Wilson’s disease: a systematic review and meta-analysis
J. Chenbhanich, C. Thongprayoon, A. Atsawarungruangkit, T. Phupitakphol, W. Cheungpasitporn
Abaloparatide-SC improves trabecular microarchitecture as assessed by trabecular bone score (TBS): a 24-week randomized clinical trial
J. P. Bilezikian, G. Hattersley, L. A. Fitzpatrick, A. G. Harris, E. Shevroja, K. Banks, B. Z. Leder, J. R. Zanchetta, D. Hans
The impact of GI events on persistence and adherence to osteoporosis treatment: 3-, 6-, and 12-month findings in the MUSIC-OS study
A. Modi, S. Sen, J. D. Adachi, S. Adami, B. Cortet, A. L. Cooper, P. Geusens, D. Mellström, J. P. Weaver, J. P. van den Bergh, P. Keown, S. Sajjan
Interaction between LRP5 and periostin gene polymorphisms on serum periostin levels and cortical bone microstructure
J. Pepe, N. Bonnet, F. R. Herrmann, E. Biver, R. Rizzoli, T. Chevalley, S. L. Ferrari
The effect of insulin on bone mineral density among women with type 2 diabetes: a SWAN Pharmacoepidemiology study
K. Ruppert, J. Cauley, Y. Lian, J. C. Zgibor, C. Derby, D. H. Solomon
Older men who sustain a hip fracture experience greater declines in bone mineral density at the contralateral hip than non-fractured comparators
A. M. Rathbun, J. Magaziner, M. D. Shardell, L. M. Yerges-Armstrong, D. Orwig, G. E. Hicks, M. C. Hochberg
Were VCF patients at higher risk of mortality following the 2009 publication of the vertebroplasty “sham” trials?
K. L. Ong, D. P. Beall, M. Frohbergh, E. Lau, J. A. Hirsch
Milk and other dairy foods and risk of hip fracture in men and women
D. Feskanich, H. E. Meyer, T. T. Fung, H. A. Bischoff-Ferrari, W. C. Willett
Comorbidities and medication use in patients with a recent clinical fracture at the Fracture Liaison Service
L. Vranken, C. E. Wyers, R. Y. Van der Velde, H. M. Janzing, S. Kaarsemaker, P. P. Geusens, J. P. Van den Bergh
Characterization of trabecular bone microstructure in premenopausal women with distal radius fractures
T. D. Rozental, F. Johannesdottir, K. C. Kempland, M. L. Bouxsein
Serum parathyroid hormone is associated with increased cortical porosity of the inner transitional zone at the proximal femur in postmenopausal women: the Tromsø Study
M. Osima, T. T. Borgen, M. Lukic, G. Grimnes, R. M. Joakimsen, E. F. Eriksen, Å. Bjørnerem
Two threshold levels of vitamin D and the prevalence of comorbidities in outpatients of a tertiary hospital
I. N. Furuie, M. J. J. Mauro, S. Petruzziello, S. C. Riechi, R. R. Petterle, C. L. Boguszewski, V. Z. C. Borba
The association between childhood fractures and adolescence bone outcomes: a population-based study, the Tromsø Study, Fit Futures
T. Christoffersen, N. Emaus, E. Dennison, A.-S. Furberg, L. Gracia-Marco, G. Grimnes, O. A. Nilsen, D. Vlachopoulos, A. Winther, L. A. Ahmed
Geisinger high-risk osteoporosis clinic (HiROC): 2013–2015 FLS performance analysis
P. Dunn, D. Webb, T. P. Olenginski
CT-based evaluation of volumetric bone density in fragility fractures of the pelvis—a matched case-control analysis
D. Schönenberg, R. Guggenberger, D. Frey, H.-C. Pape, H.-P. Simmen, G. Osterhoff
Risk of venous thromboembolism among users of different anti-osteoporosis drugs: a population-based cohort analysis including over 200,000 participants from Spain and the UK
E. Martín-Merino, I. Petersen, S. Hawley, A. Álvarez-Gutierrez, S. Khalid, A. Llorente-Garcia, A. Delmestri, M. K. Javaid, T. P. Van Staa, A. Judge, C. Cooper, D. Prieto-Alhambra
Defective WNT signaling associates with bone marrow fibrosis—a cross-sectional cohort study in a family with WNT1 osteoporosis
R. E. Mäkitie, R. Niinimäki, S. Kakko, T. Honkanen, P. E. Kovanen, O. Mäkitie
Spanish consensus on treat to target for osteoporosis
X. Nogués, J. M. Nolla, E. Casado, E. Jódar, M. Muñoz-Torres, J. M. Quesada-Gómez, L. Canals, M. Balcells, L. Lizán
Teriparatide for treatment of patients with bisphosphonate-associated atypical fracture of the femur
S. L. Greenspan, K. Vujevich, C. Britton, A. Herradura, G. Gruen, I. Tarkin, P. Siska, B. Hamlin, S. Perera
A case of regional migratory osteoporosis
J. Spierings, S. Bours, H.R.M. Peeters
Asfotase alfa treatment for 1 year in a 16 year-old male with severe childhood hypophosphatasia
S. A. Bowden, B. H. Adler
Worsening of soft tissue dystrophic calcification in an osteoporotic patient treated with teriparatide
T. D. Htet, J. A. Eisman, G. J. Elder, J. R. Center
Bisphosphonate drug holidays in postmenopausal osteoporosis: effect on clinical fracture risk. Response to comments by Bredemeier
Julien Paccou, Bernard Cortet